CDMO News
Novo Nordisk Acquires Alkermes’ Athlone Manufacturing Site
Alkermes plc, a pharmaceutical company, has announced the completion of the sale of its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. The transaction, which closed recently, involved a one-time cash payment of approximately $91 million for the
7 May 2024